CBD

Midas Letter

Midas Letter Live- Strainprint CTO on Cannabis At Work Partnership

Strainprint’s CTO, David Berg, recently sat down with the Midas Letter Live to talk about our partnership with Cannabis At Work. About Midas Letter is the journal of “best-in-class” companies in all sectors. Publisher James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business […]

Limonene

Understanding Terpenes — Limonene

To learn more about this mood enhancing, appetite suppressing terpene, head over to the Strainprint Community…

Angry and Alone

Cannabis for Conditions: Social Anxiety

While some social anxiety sufferers find great efficacy with cannabis, its use is complicated by the polarized and subjective responses of different patients. For example, a single sample of cannabis can relax and soothe one person while eliciting in another a full-blown panic attack. Continue reading to learn more….

Cannabis Diabetes

How Cannabis May Help Boost Your Diabetes Care Routine

Are you a cannabis user with Diabetes? Many positive benefits have been discovered that help you manage, and in some cases even reverse, your diabetes symptoms. Read more in the Strainprint Community…

The Growth Op

Strainprint Featured in the Growth Op – Online, cannabis education resource offers patients, canna-curious consumers a safe space

Online, cannabis education resource offers patients, canna-curious consumers a safe space

CTV News

Strainprint Featured in CTV News – Canadian tech companies look to cash in on cannabis with innovations and apps

Strainprint, which has focused on medical marijuana users but works just as well for recreational users, launched the day before legalization to take advantage of the attention pot would garner.